Reverse Phase HPLC Profiling of Antioxidant and Antimicrobial Activities of Sarcochlamys pulcherrima (Roxb.) Gaud.
DOI:
https://doi.org/10.3329/icpj.v5i6.27709Keywords:
Sarcochlamys pulcherrima, Total phenol, Total flavonoid, Antioxidant, Antimicrobial, HPLCAbstract
The total phenolics content, total flavonoids content, antioxidant activity and antimicrobial activity of methanol extract and its derived fractions from Sarcochlamys pulcherrima (Roxb.) Gaud. were evaluated. The plant material was initially extracted with methanol. The fractionation was carried out using liquid-liquid extraction with hexane, ethyl acetate, n-butanol, and water. The Folin-Ciocalteu assay was used to quantify total phenolics content, Aluminum Chloride assay to quantify total flavonoids content, DPPH (2, 2-diphenyl-1-picrylhydrazine) and reducing power assay are to determine antioxidant activity. The ethyl acetate fraction was observed to contain high phenolic content (201.37 mg/g) followed by n-butanol fraction (197.76 mg/g), methanol extract (136.93mg), water fraction (55.05mg/g) and hexane fraction (36.94mg/g) respectively. The flavonoids content ranges from 109.48 mg/g to 8.63 mg/g dry extract. The highest antioxidant activity was found in n-butanol fraction (EC50 =14.69 µg/mL in DPPH and 162.65 µg/mL in reducing power). The antimicrobial activity of the samples was evaluated based on inhibition zone using agar-well diffusion assay and minimal inhibition concentration (MIC) values. Hexane fraction had no antimicrobial effect against test microorganisms. The zone of inhibitions ranged from 11 mm to 6 mm. The n-butanol fraction possessed the highest antimicrobial activity against E. coli among the four fractions with MIC value of 0.781mg/mL. In addition rutin, gallic acid, quercetin and kaempferol were quantified by reverse phase high performance liquid chromatography (HPLC) method. In ethyl acetate and n-butanol fraction, observed large amount rutin (77.53 ± 7.57 mg/g; 77.45 ± 1.71 mg/g) and gallic acid (61.01 ± 2.34 mg/g; 22.75 ± 1.54 mg/g) as compared to the quercetin and kaempferol.
Doley et al., International Current Pharmaceutical Journal, May 2016, 5(6): 49-54
Downloads
123
86
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).